Effectiveness of pembrolizumab in patients with urothelial carcinoma receiving proton pump inhibitors
Wataru Fukuokaya(Jikei University School of Medicine), Shin Egawa, Shoji Kimura(Jikei University School of Medicine), Fumihiko Urabe(Jikei University School of Medicine), Kosuke Iwatani(Jikei University School of Medicine), Naoki Terada(Kyoto University), Haruhito Azuma(Osaka University of Pharmaceutical Sciences), Jun Miki(Jikei University School of Medicine), Kazuki Nishimura(Osaka University of Pharmaceutical Sciences), Takafumi Yanagisawa(Jikei University School of Medicine), Shunsuke Tsuzuki(Jikei University School of Medicine), Yu Imai(Jikei University School of Medicine), Kazumasa Komura(Kawasaki Medical School), Takahiro Kimura(Jikei University School of Medicine), Shoichiro Mukai, Hirokazu Abe(Kameda Medical Center), Yu Oyama(Kameda Medical Center), Kagenori Ito(Jikei University School of Medicine), Taizo Uchimoto(Osaka University of Pharmaceutical Sciences), Toshiyuki Kamoto(Kyoto University)
Cited by 24
Related Papers
Extracellular vesicles as biomarkers and therapeutic targets for cancer
|American Journal of Physiology-Cell Physiology|2019|412
Circulating miRNA panels for specific and early detection in bladder cancer
|Cancer Science|2018|282
Blockade of T-cell costimulation prevents development of experimental chronic renal allograft rejection.
|Proceedings of the National Academy of Sciences|1996|167
Diagnostic performance of multidetector computed tomographic (MDCTU) in upper tract urothelial carcinoma (UTUC): a systematic review and meta-analysis
|World Journal of Urology|2019|134
Large-scale Circulating microRNA Profiling for the Liquid Biopsy of Prostate Cancer
|Clinical Cancer Research|2019|129